M4MM
High-Potency Cannabis Strains Impact Legal and Health Systems
LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...
New Zealand Approves Psilocybin for Medicinal Use
LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...
Psyence Group Inc. Announces C$600,000 Private Share Offering
LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...
MJ and MSOS ETFs Signal High Upside on U.S. Legalization Outlook
LOS ANGELES- Investment in cannabis-focused ETFs such as Amplify’s MJ and AdvisorShares’ MSOS reflects growing investor anticipation of federal legalization-driven expansion, even amid pronounced volatility and structural headwinds. Analysts argue that rescheduling cannabis from Schedule I ...
Legislative Wave Follows Growth of Hemp-Infused Beverage Market
LOS ANGELES- The market for hemp-derived cannabis beverages has expanded rapidly since the 2018 federal legalization of hemp, reaching an estimated value of over $1 billion today and projected to exceed $30 billion by 2035. ...
Canadian Cannabis Producers Expand Exports
LOS ANGELES- Canada’s licensed cannabis sector continues its move toward international markets, driven by strong global demand, especially for medical cannabis. During the 2023–24 fiscal year, Canada exported approximately CA$218 million of medical cannabis for commercial ...
Big Cannabis Companies Maintain Optimism in Florida Despite Adult‑Use Setback
LOS ANGELES- Major cannabis operators remain confident in the Florida medical market, viewing it as a strategic long‑term growth opportunity despite the failed November 2024 attempt to legalize adult‑use cannabis. In a recent analysis, Forbes ...
High-Potency Cannabis Strains Impact Legal and Health Systems
LOS ANGELES— The expansion of high-potency cannabis products—such as concentrated extracts, edibles, and potent vaping liquids is increasingly challenging health-care facilities and legal systems across North America. Emergency departments in the U.S. and Canada report ...
New Zealand Approves Psilocybin for Medicinal Use
LOS ANGELES— New Zealand’s government has authorized the prescription of psilocybin, the psychoactive compound found in so‑called “magic mushrooms,” for patients with treatment‑resistant depression. This marks the first time psilocybin has been approved for medical use ...
Psyence Group Inc. Announces C$600,000 Private Share Offering
LOS ANGELES— Psyence Group Inc. a biotechnology firm focused on nature-derived psilocybin for mental health and palliative care, has announced a non-brokered private placement to raise up to C$600,000. The offering, detailed in a news ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Why Bob Hoban Is Defending Steve DeAngelo—And What It Reveals About Cannabis Policy
LOS ANGELES- In cannabis industry discourse, facts can be overshadowed by simplified narratives. One such claim—widely circulated in trade circles—is that Steve DeAngelo, founder of Harborside and a prominent figure in the legalization movement, was ...
DEA Grants Import Permit for Psilocybin Truffles to Red Light Holland and Irvine Labs
LOS ANGELES- Red Light Holland Corp, an Ontario-based producer of psilocybin truffles, announced that its U.S. partner, Irvine Labs, has received a Controlled Substances Import Permit from the Drug Enforcement Administration (DEA). This authorization allows ...
Glass House Brands Proposes Long-Term Incentive Plan Tied to Share Price Performance
LOS ANGELES- Glass House Brands Inc. a vertically integrated cannabis company, has announced the mailing of its management information circular to shareholders ahead of its annual and special meeting scheduled for June 20, 2025. At ...
Minnesota Legislature Advances Cannabis Market Framework to Governor
LOS ANGELES- Minnesota lawmakers have passed a comprehensive bill aimed at refining the state's adult-use cannabis program, forwarding it to Governor Tim Walz for approval. The legislation, known as SF 2370, seeks to address regulatory ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Rubicon Organics Appoints Glen Ibbott as Interim CFO
LOS ANGELES- Rubicon Organics Inc. a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...
TILT Holdings Reports First Quarter 2025 Financial Results
LOS ANGELES- TILT Holdings Inc. announced its financial results for the first quarter ended March 31, 2025, reflecting a year-over-year revenue decline and continued strategic realignment towards its Jupiter inhalation technology business. Financial Performance The ...
High-Paying Roles in the Cannabis Industry
LOS ANGELES- As the cannabis industry continues its expansion across the United States, it presents a variety of high-paying career opportunities. Positions such as cultivation directors, compliance officers, and extraction technicians are in demand, offering ...
German Medical Cannabis Market Sees Significant Growth
LOS ANGELES- Germany's medical cannabis industry is experiencing substantial growth, driven by recent regulatory reforms and increasing patient demand. Companies such as Cantourage are at the forefront of this expansion, capitalizing on the evolving legal ...
Canopy Growth Introduces Targeted Product Expansion for Canadian Market
LOS ANGELES- Canopy Growth Corporation has announced a strategic expansion of its product portfolio, focusing on four high-demand segments within Canada's adult-use cannabis market: vapes, high-THC flower, pre-rolls, and edibles. This initiative is part of ...
U.S. Legal Cannabis Sales Surpass $30 Billion in 2024
LOS ANGELES- In 2024, legal cannabis sales in the United States reached $30.1 billion, marking a 4.5% increase from the previous year. This growth occurred despite a 3.4% reduction in industry employment, equating to approximately ...
iAnthus Capital Holdings Reports Q1 2025 Financial Results
LOS ANGELES- iAnthus Capital Holdings, Inc. a multi-state operator in the U.S. regulated cannabis industry, released its financial results for the first quarter ended March 31, 2025. Financial Highlights Revenue: $38.1 million, a decrease from ...
